Fujisawa Masato, Nakamura Takeshi, Ohno Masakazu, Miyazaki Jiro, Arakawa Soichi, Haraguchi Takahiro, Yamanaka Nozomu, Yao Akihisa, Matsumoto Osamu, Kuroda Yoshikazu, Kamidono Sadao
Division of Urology, Department of Organs Therapeutics, Kobe University Graduate School of Medicine, Kobe, Japan.
Urology. 2002 Dec;60(6):983-7. doi: 10.1016/s0090-4295(02)01987-8.
To review cases of colorectal cancer requiring urologic management to clarify the role the urologist should play in the surgical procedures. A deterrent to radical surgery for advanced colorectal carcinoma with urinary involvement is the technical complexity and associated morbidity and mortality of this procedure.
Thirty-six tumors in 35 patients, including 19 sigmoid cancers (Stage II, 17; Stage III, 2), 12 rectal cancers (Stage II, 11; Stage III, 1), and 5 local recurrences of colorectal carcinoma in the pelvis were reviewed. All tumors had invaded the bladder, prostate, or ureter. The demographic and clinical characteristics, type of operative procedure, and postoperative complications were analyzed.
Of the patients with a sigmoid tumor, partial cystectomy was performed in 15 patients who underwent a bladder-sparing procedure; an ileal conduit and ileal neobladder were created in 2 patients each who required cystectomy. Four patients with rectal cancer underwent a bladder-sparing procedure: partial cystectomy in 1, partial cystectomy with ileal ureter in 1, and prostatectomy in 2. The remaining 8 patients underwent cystectomy with the following types of reconstruction: colonic neobladder in 1, ileal neobladder in 4, Indiana pouch in 1, ileal conduit in 1, and ureterocutaneostomy in 1 patient. The bladder was spared in a greater percentage of patients with sigmoid cancer than in those with rectal cancer. The incidence of complications was greater in patients with rectal cancer and local recurrence than in those with sigmoid tumors. The complication rate was especially low in patients who underwent a bladder-sparing procedure (10.5%) compared with patients who required cystectomy (58.3%). The survival in patients with sigmoid cancer who underwent bladder-sparing surgery also was better than in those who underwent cystectomy.
The treatment of advanced colorectal cancer is best managed by a committed team that includes an experienced urologist. Urologists play a critical role in determining the surgical options and creating appropriate urinary diversions to achieve curative resection with the highest quality of life.
回顾需要泌尿外科处理的结直肠癌病例,以明确泌尿外科医生在手术过程中应发挥的作用。晚期结直肠癌伴泌尿系统受累时,根治性手术的一个阻碍因素是该手术的技术复杂性以及相关的发病率和死亡率。
对35例患者的36个肿瘤进行了回顾,其中包括19例乙状结肠癌(II期17例,III期2例)、12例直肠癌(II期11例,III期1例)以及5例盆腔内结直肠癌局部复发。所有肿瘤均侵犯了膀胱、前列腺或输尿管。分析了患者的人口统计学和临床特征、手术方式以及术后并发症。
在乙状结肠肿瘤患者中,15例接受了保留膀胱手术的患者进行了部分膀胱切除术;2例需要膀胱切除术的患者分别进行了回肠造口术和回肠新膀胱术。4例直肠癌患者接受了保留膀胱手术:1例进行了部分膀胱切除术,1例进行了部分膀胱切除术加回肠输尿管术,2例进行了前列腺切除术。其余8例患者接受了膀胱切除术及以下类型的重建:1例为结肠新膀胱术,4例为回肠新膀胱术,1例为印第安纳袋术,1例为回肠造口术,1例为输尿管皮肤造口术。乙状结肠癌患者中保留膀胱的比例高于直肠癌患者。直肠癌和局部复发患者的并发症发生率高于乙状结肠肿瘤患者。与需要膀胱切除术的患者(58.3%)相比,接受保留膀胱手术的患者并发症发生率特别低(10.5%)。接受保留膀胱手术的乙状结肠癌患者的生存率也高于接受膀胱切除术的患者。
晚期结直肠癌的治疗最好由一个包括经验丰富的泌尿外科医生在内的专业团队来进行管理。泌尿外科医生在确定手术方案和创建合适的尿流改道以实现根治性切除并获得最高生活质量方面发挥着关键作用。